申请人:Ikeda Mohando Co., Ltd.
公开号:EP0111685A1
公开(公告)日:1984-06-27
This invention relates to new heterocyclic compounds having the general formula shown below, and medically allowable salts, hydrates and solvates thereof:
These heterocylclic compounds are effective as antagonists against histamine H2 receptors. They also show gastric mucus secretion-accelerating activities and are useful as agents for protecting and reinforcing the gastric mucosal surface. The heterocyclic compounds are therefore extremely useful as agents for peptic ulcer.
本发明涉及具有下式通式的新杂环化合物及其医学上允许的盐、水合物和溶液:这些杂环化合物作为组胺 H2 受体的拮抗剂是有效的。 它们还具有促进胃粘液分泌的活性,可用作保护和加固胃粘膜表面的药物。 因此,这些杂环化合物作为治疗消化性溃疡的药物极为有用。